Microarray Market 2018 – North America Industry Size, Share, Analysis, Trend & Future Strategic Planning

-
Market research future published a cooked research report on North America Microarray Market. The North America market for microarray is growing slowly and expected to reach USD 1.63 Billion by the end of 2027.
The North America Microarray Market for is increasing rapidly. A microarray is a multiplex lab-on-a-chip. It is a 2D array on a solid substrate, usually a glass slide or silicon thin-film cell, that assays large amounts of biological material using high-throughput screening miniaturized, multiplexed and parallel processing and detection methods. Globally the microarray market is dominated by DNA microarrays. The protein microarray is currently the fastest growing market. The use of peptide and carbohydrate microarrays is expanding. Tissue and cell microarrays are in their infancy stage and are developing slowly because of many complications in the process development. North American market for Microarray is expected to grow at the rate of about 4.0% from 2016 to 2027.
Key Finding
  • The North America Microarray Market is expected to reach $1,635.4 billion by 2027.
  • Paraffin tissue sections (FFPE) hold the largest share of 54.6% of the North America Tissue Microarray market.
  • U.S. holds the largest market share of North America Tissue Microarray market and is anticipated to reach $364.2 million by the end of 2027.
  • Immunohistochemistry segment holds the largest market share of 47.5% in 2015.
Segmentation:
North America Microarray Market has been segmented on the basis of types which comprises of protein microarray, tissue microarray, and cellular microarray. On the basis of product, North America Tissue microarray market is segmented into paraffin tissue sections (FFPE), frozen tissue sections, and others. On the basis of applications, tissue microarray market is segmented into immunohistochemistry, in-situ hybridization, and others.
Access for Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/2641 .
North America Microarray Market Players:
The major participants of this market are ABCAM, Asterand Bioscience, IHC World LLC, Novus Biologicals LLC (Acquired By BIO-TECHNE), Origene Technologies Inc, Pantomics, Inc, Protein Biotechnologies Inc, US Biomax, Inc., US Bioupton Int, Vitrovivo Biotech, LLC And Others
Regional Analysis:
North America tissue microarray market is segmented into two countries: United States, and Canada. U.S. is the largest market for tissue microarray. The U.S market for tissue microarray is expected to reach at USD 364.2 million by the end of the forecasted period. Canada is the second-largest market for tissue microarray which is expected to grow at a CAGR of 4.4%.
…Continued
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312

Comments

Post a Comment

Popular posts from this blog

Actinic Keratosis Treatment Market Share, Demand, New Opportunities and Foresight to 2024

-
Market Research Future has added a report titled “Actinic Keratosis Treatment Market Research Report- Forecast to 2024” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe. Report Overview: Rise in the diagnosis efficiency of various types of cancers especially those related to the skin such as actinic keratosis are growing promptly. The treatment of actinic keratosis is gaining increasing prominence due to an extensive range of factors that are contributing to the expansion of the market. Actinic keratosis is a commonly diagnosed skin disorder that can potentially progress to non-melanoma skin cancers, this particular characteristic of the disease has contributed to the demand for its treatment significantly. A typical patient example with actinic keratosis is usually observed as having fair and sun-sensitive skin. Get Premium Copy @  https://www.marketr
Read more

Wearable Medical Device Market Poised for Steady Growth in the Future 2027

-
The Global  Wearable Medical Device   Market  Research   Report provides detailed analysis of the key regional market status of the Healthcare Industry. The  Wearable Medical Device Market  is expected to reach USD 4 billion in the forecasted period. The market is expected to grow at a CAGR of 26.78%. This growth in the market can be due to various factors such as increasing focus on fitness among individuals and awareness about healthy lifestyle. Furthermore signi8ficant growth in the home healthcare is expected to push up the demand for this segment. Top key players in the  wearable Medical Device market  are:  Fitbit Inc., Garmin, Vital Connect, Omron Corp., Sotera Wireless, Jawbone, Pebble Technology Corp., Basis Science Inc., Withings, Intelesens Ltd., Covidien Plc, LifeWatch AG, Polar Electro, Philips Electronics, and Everist Genomics. Get Sample copy at  https://www.marketresearchfuture.com/sample_request/899  . Segments The  Wearable Medical Device Market  can be
Read more

Peripheral Artery Disease Market Will Watch a Sensational Development by 2023: Industry Assertions by MRFR

-
MRFR is the Leading Brand in The Research Company who Recently Published Peripheral Artery Disease Market Research Reports which includes Study of growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Upcoming Trends and Forecast to 2023. Get Sample Copy @   https://www.marketresearchfuture.com/sample_request/1540 Industry Leading Players: Boston Scientific Corporation, KONINKLIJKE PHILIPS N.V, Abbott, Medtronic, B. Braun Melsungen AG, TERUMO CORPORATION, Becton, Dickinson and Company (BD), Sanofi S.A., Johnson & Johnson Services, Inc., AstraZeneca Plc., Angioscore, Inc., Bristol-Myers Squibb Company, Betagenon AB, Proteon Therapeutics, Inc., Merck & Co., Inc., Bayer HealthCare Pharmaceuticals, Symic Bio, Inc., CardioVascular BioTherapeutics, Inc., AnGes, Inc., TheraVasc Inc., Smith & Nephew plc, Stryker Corporation, Cook Medical, Cordis, Aspen Surgical Products, Inc., Alcon Laboratories, Inc., Zimmer Biomet Holdings, Inc., and others are some of
Read more